Disinfection Leader TOMI Targets $120 Million Merger to Diversify Operations
Frederick, Friday, 8 May 2026.
Today, TOMI announced a strategic $120 million merger intent with Carbonium Core, diversifying its core disinfection business into advanced materials alongside a solid five percent first-quarter revenue increase.
A Strategic Pivot Toward Advanced Materials
On April 30, 2026, TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) executed a non-binding letter of intent (LOI) to merge with Carbonium Core, Inc., a U.S.-based manufacturer specializing in nuclear-grade graphite for advanced reactor technologies [1]. This proposed transaction assigns an implied enterprise valuation of $120 million to Carbonium Core [1][2]. Under the outlined terms, TOMI will acquire all issued and outstanding shares of the advanced materials producer [1]. In return, Carbonium Core stockholders are slated to receive shares of TOMI common stock equivalent to 19.99% of TOMI’s outstanding shares immediately prior to the merger, alongside a newly established series of preferred stock that can be converted into TOMI common stock, pending stockholder approval [1].
Financial Health and Operational Efficiency
The merger announcement coincides with TOMI’s first-quarter financial results for the period ending March 31, 2026, released today, May 8, 2026 [1]. The company posted a revenue of $1,654,000, representing a 5% year-over-year growth compared to the first quarter of 2025, and a notable 67% surge from the fourth quarter of 2025 [1][2]. Operational efficiencies were a focal point, as TOMI successfully reduced operating expenses by 15% while simultaneously driving a 139% increase in applicator sales [1]. Despite these top-line improvements, the company still reported a net loss of $811,000, translating to a loss of $0.04 per basic and diluted share [1], a figure that aligns with the mathematical distribution across its 20,696,686 outstanding shares -0.039.
Public Health Crises Drive Core Business Demand
While the Carbonium Core merger sets a new trajectory, TOMI’s legacy biodefense technology remains highly relevant amidst ongoing global health challenges [GPT]. On May 6, 2026, international health authorities responded to a severe hantavirus outbreak aboard an Atlantic cruise ship, which tragically resulted in six confirmed cases and three fatalities [2]. In response to the heightened need for rapid, professional remediation, TOMI has actively promoted its SteraMist ionized Hydrogen Peroxide (iHP) technology [2]. The system, originally developed under a defense grant with DARPA, deploys a non-corrosive fog that rapidly oxidizes the lipid membranes of enveloped viruses, making it uniquely suited to neutralize rodent-borne pathogens like hantavirus without damaging sensitive maritime infrastructure [2].